Literature DB >> 16890211

Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes.

Adrienne Laskowski1, Owen L Woodman, Anh H Cao, Grant R Drummond, Tanneale Marshall, David M Kaye, Rebecca H Ritchie.   

Abstract

OBJECTIVE: Reactive oxygen species (ROS) such as superoxide have been linked to the hypertrophic response of the heart to stimuli including angiotensin II (AngII), mechanical stretch, and pressure overload. We have previously demonstrated that cGMP and protein kinase G mediate the antihypertrophic actions of the natriuretic peptides in rat cardiomyocytes and isolated whole hearts. The impact of natriuretic peptides on cardiac ROS generation, however, has not been investigated. We tested the hypothesis that reduced superoxide accumulation contributes to the antihypertrophic action of atrial natriuretic peptide (ANP).
METHODS: Neonatal rat cardiomyocytes were cultured in serum-free medium with and without AngII (1 micromol/L) or endothelin-1 (ET(1), 60 nmol/L) in the presence and absence of ANP (1 micromol/L) or tempol (100 micromol/L). Hypertrophic responses, cardiomyocyte superoxide generation, and cardiomyocyte expression of NADPH oxidase were determined.
RESULTS: AngII induced increases in cardiomyocyte size (to 176 +/- 9% n = 8 p < 0.001, at 48 h), beta-myosin heavy chain expression (to 4.0 +/- 1.6-fold n = 6 p < 0.05, at 48 h), c-fos expression (to 1.9 +/- 0.5-fold n = 7 p < 0.01, at 6 h), superoxide generation (to 181+/-21% n = 8 p < 0.005, at 24 h), and expression of the gp91phox subunit of NADPH oxidase (to 2.4 +/- 0.5-fold n = 7 p < 0.05, at 48 h). These effects were all significantly inhibited by ANP: cardiomyocyte size, beta-myosin heavy chain expression, c-fos expression, superoxide generation and gp91phox expression were reduced to 107 +/- 5% (n = 5 p < 0.05), 1.2 +/- 0.2-fold (n = 6 p < 0.05), 0.9 +/- 0.2-fold (n = 7 p < 0.05), 141 +/- 21% (n = 8 p < 0.05), and to 1.0 +/- 0.5-fold (n = 7 p < 0.05), respectively. These effects were mimicked by tempol. ANP and tempol also significantly inhibited ET1-induced increases in cardiomyocyte size and superoxide generation, but had no effect on markers of hypertrophy when studied alone.
CONCLUSION: This data indicates that the antihypertrophic actions of ANP are accompanied by reduced levels of superoxide, suggesting an antioxidant action contributes to the antihypertrophic actions of ANP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890211     DOI: 10.1016/j.cardiores.2006.07.006

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  22 in total

1.  Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.

Authors:  K Huynh; H Kiriazis; X-J Du; J E Love; K A Jandeleit-Dahm; J M Forbes; J R McMullen; R H Ritchie
Journal:  Diabetologia       Date:  2012-02-29       Impact factor: 10.122

2.  Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor.

Authors:  M Flores-Muñoz; N J Smith; C Haggerty; G Milligan; S A Nicklin
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

3.  Role of Nongenomic Signaling Pathways Activated by Aldosterone During Cardiac Reperfusion Injury.

Authors:  Anthony W Ashton; Thi Y L Le; Celso E Gomez-Sanchez; Marie-Christine Morel-Kopp; Brett McWhinney; Amanda Hudson; Anastasia S Mihailidou
Journal:  Mol Endocrinol       Date:  2015-06-29

Review 4.  Cardiac NO signalling in the metabolic syndrome.

Authors:  O Pechánová; Z V Varga; M Cebová; Z Giricz; P Pacher; P Ferdinandy
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

5.  Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts.

Authors:  Arumugam Parthasarathy; Venkatachalam Gopi; Subramanian Umadevi; Anoop Simna; Mohammed Jainuddin Yousuf Sheik; H Divya; Elangovan Vellaichamy
Journal:  Mol Cell Biochem       Date:  2013-03-23       Impact factor: 3.396

6.  Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II.

Authors:  Walid Mokni; Thérèse Keravis; Nelly Etienne-Selloum; Alison Walter; Modou O Kane; Valérie B Schini-Kerth; Claire Lugnier
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

7.  Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.

Authors:  R H Ritchie; J E Love; K Huynh; B C Bernardo; D C Henstridge; H Kiriazis; Y K Tham; G Sapra; C Qin; N Cemerlang; E J H Boey; K Jandeleit-Dahm; X-J Du; J R McMullen
Journal:  Diabetologia       Date:  2012-09-22       Impact factor: 10.122

8.  Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide.

Authors:  Qinghua Zeng; Qingwei Zhou; Fanrong Yao; Stephen T O'Rourke; Chengwen Sun
Journal:  J Pharmacol Exp Ther       Date:  2008-06-06       Impact factor: 4.030

9.  NPRA-mediated suppression of AngII-induced ROS production contribute to the antiproliferative effects of B-type natriuretic peptide in VSMC.

Authors:  Pan Gao; De-Hui Qian; Wei Li; Lan Huang
Journal:  Mol Cell Biochem       Date:  2008-12-23       Impact factor: 3.396

10.  Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function.

Authors:  Rebecca H Ritchie; Chen Huei Leo; Chengxue Qin; Erin J Stephenson; Marissa A Bowden; Keith D Buxton; Sarah J Lessard; Donato A Rivas; Lauren G Koch; Steven L Britton; John A Hawley; Owen L Woodman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-21       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.